Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Aug 6, 2015 · 10-Q · 37 days after period end · 0001193125-15-281202
| Metric | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|
| Net Income | -$15.11M | -$10.17M | -$6.14M |
| EPS Diluted | -$0.63 | -$0.91 | -$14.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 6, 2015 · 37 d after period end
